Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RPAY | Class A Common Stock | Options Exercise | $44.1K | +7.2K | +5.14% | $6.13 | 147K | Sep 6, 2024 | Direct | |
transaction | RPAY | Class A Common Stock | Sale | -$58.9K | -7.2K | -4.89% | $8.18 | 140K | Sep 6, 2024 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RPAY | Stock Option (right to buy) | Options Exercise | $0 | -7.2K | -3.76% | $0.00 | 184K | Sep 6, 2024 | Class A Common Stock | 7.2K | $6.13 | Direct | F2, F3 |
Id | Content |
---|---|
F1 | The sales price indicated is a weighted average sales price. The corresponding shares were sold in multiple transactions at prices ranging from $8.12 to $8.33 inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth. |
F2 | The terms of the stock option, representing a right to acquire 191,470 shares of Class A common stock of the Issuer, provide for vesting and exercisability in three separate tranches as follows: (a) 31% shall vest and become exercisable on the later of (i) March 19, 2024 and (ii) the date on which the closing price per share of Class A common stock has equaled or exceeded $10.00 for any consecutive 20 day trading period ending on or prior to March 18, 2028; (b) 32% shall vest and become exercisable on the later of (i) March 19, 2025 and (ii) the date on which the closing price per share of Class A common stock has equaled or exceeded $14.50 for any consecutive 20 day trading period ending on or prior to March 18, 2028; and (c) 37% shall vest and become exercisable on the later of (i) March 19, 2026 and (ii) the date on which the closing price per share of Class A common stock has equaled or exceeded $19.54 for any consecutive 20 day trading period ending on or prior to March 18, 2028. |
F3 | The first tranche vested on April 9, 2024. The two other tranches remain unvested at this time. |